Avalglucosidase Alfa Extension Study

Clinical trial NCT02032524 · COMPLETED

Trial details

NCT number: NCT02032524
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glycogen Storage Disease Type II Pompe Disease

Start date: 2014-02-27
Primary completion: 2022-12-12
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.